{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:24:22Z","timestamp":1778887462402,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":579,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.5604\/01.3001.0010.5274","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T03:06:23Z","timestamp":1508209583000},"page":"842-850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Endoscopic Management of Primary Sclerosing Cholangitis"],"prefix":"10.1016","volume":"16","author":[{"given":"Jodie A.","family":"Barkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico O.","family":"Souto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.5604\/01.3001.0010.5274_bib0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(80)90131-6","article-title":"Clinicopathologic features of the syndrome of primary sclerosing cholangitis","volume":"79","author":"Wiesner","year":"1980","journal-title":"Gastroenterolo-gy"},{"key":"10.5604\/01.3001.0010.5274_bib0015","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1038\/ctg.2015.33","article-title":"Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis","volume":"6","author":"Sclair","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0020","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"key":"10.5604\/01.3001.0010.5274_bib0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MOG.0b013e3282f9e239","article-title":"An update on primary sclerosing cholangitis","volume":"24","author":"Maggs","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0030","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/ibd.22938","article-title":"Primary scleros-ing cholangitis is associated with a distinct phenotype of inflammatory bowel disease","volume":"18","author":"Boonstra","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.5604\/01.3001.0010.5274_bib0035","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(91)70019-T","article-title":"Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis","volume":"199","author":"Olsson","year":"1991","journal-title":"Gastroenterolo-gy"},{"key":"10.5604\/01.3001.0010.5274_bib0040","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0010.5274_bib0045","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/liv.13354","article-title":"An update on cancer risk and surveillance in primary sclerosing cholangitis","volume":"37","author":"Horsley-Silva","year":"2017","journal-title":"Liver Int"},{"key":"10.5604\/01.3001.0010.5274_bib0050","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"52","author":"Fevery","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.5604\/01.3001.0010.5274_bib0055","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient Age Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.5604\/01.3001.0010.5274_bib0060","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"American College of Gastroenterology. ACG Clinical Guideline: Primary Sclerosing Cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0065","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-0043-107029","article-title":"Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline","volume":"49","author":"Aabakken","year":"2017","journal-title":"Endos-copy"},{"key":"10.5604\/01.3001.0010.5274_bib0070","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0010.5274_bib0075","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0168-8278(00)80002-1","article-title":"Magnetic resonance cholangiogra-phy in patients with biliary disease: its role in primary sclero-sing cholangitis","volume":"33","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0010.5274_bib0080","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cgh.2005.10.007","article-title":"Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary scle-rosing cholangitis","volume":"4","author":"Berstad","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0010.5274_bib0085","series-title":"Hepatology","article-title":"MRI working group of the IPSCSG. Recommendations on the use of MRI in PSC-A position statement from the International PSC study group","author":"Schramm","year":"2017"},{"key":"10.5604\/01.3001.0010.5274_bib0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography","volume":"256","author":"Dave","year":"2010","journal-title":"Radiology"},{"key":"10.5604\/01.3001.0010.5274_bib0095","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-2007-966253","article-title":"The roles of magnetic resonance and endoscopic retrograde cholangiopancreatography (MRCP and ERCP) in the diagnosis of patients with suspected sclerosing cholangitis: a cost-effectiveness analysis","volume":"39","author":"Meagher","year":"2007","journal-title":"Endoscopy"},{"key":"10.5604\/01.3001.0010.5274_bib0100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0010.5274_bib0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0110","first-page":"685","article-title":"Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group","volume":"8","author":"Okolicsanyi","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0010.5274_bib0115","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","article-title":"Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience","volume":"24","author":"Chapman","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0010.5274_bib0120","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2006-933564","article-title":"Primary sclerosing cholangitis: the role of endo-scopic therapy","volume":"26","author":"Stiehl","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.5604\/01.3001.0010.5274_bib0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11894-006-0011-y","article-title":"Primary sclerosing cholangitis treated by endoscopic biliary dilation: review and long-term follow-up evaluation","volume":"8","author":"Johnson","year":"2006","journal-title":"Curr Gastroenterol Rep"},{"key":"10.5604\/01.3001.0010.5274_bib0135","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0010.5274_bib0140","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1055\/s-0041-110792","article-title":"Screening primary sclerosing cholangi-tis and biliary dysplasia with endoscopic retrograde cholan-giography and brush cytology: risk factors for biliary neoplasia","volume":"48","author":"Boyd","year":"2016","journal-title":"Endoscopy"},{"key":"10.5604\/01.3001.0010.5274_bib0145","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s10620-012-2401-3","article-title":"Increased serum levels of carbohydrate antigen 19-9 and outcomes in primary sclerosing cholangitis patients without cholangiocarcinoma","volume":"58","author":"Venkatesh","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.5604\/01.3001.0010.5274_bib0150","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.gie.2013.09.015","article-title":"Diagnostic yield of bile duct brushings for cholangiocar-cinoma in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"79","author":"Trikudanathan","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.5604\/01.3001.0010.5274_bib0155","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jhep.2014.07.032","article-title":"Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET","volume":"61","author":"Sangfelt","year":"2014","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0010.5274_bib0160","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1572-0241.2007.01776.x","article-title":"Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures","volume":"103","author":"Levy","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0165","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/hep.23277","article-title":"Long-term outcomes of positive fluorescence in situ hybridization tests in primary scle-rosing cholangitis","volume":"51","author":"Bangarulingam","year":"2010","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0010.5274_bib0170","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/00365521.2016.1263681","article-title":"Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis","volume":"52","author":"Quinn","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0175","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/ajg.2011.272","article-title":"Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma","volume":"106","author":"Barr Fritcher","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1756283X14564674","article-title":"Triple modality testing by en-doscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma","volume":"8","author":"Nanda","year":"2015","journal-title":"Therap Adv Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0185","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1572-0241.2006.00383.x","article-title":"Is there a role for cholangioscopy in patients with primary sclerosing cholangitis?","volume":"101","author":"Awadallah","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0190","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0029-1215178","article-title":"Endoscopic retrograde cholangiog-raphy versus peroral cholangioscopy to evaluate intraepithelial tumor spread in biliary cancer","volume":"41","author":"Kawakami","year":"2009","journal-title":"Endoscopy"},{"key":"10.5604\/01.3001.0010.5274_bib0195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gie.2012.10.011","article-title":"Comparison of the diagnostic accuracy of peroral video-cholangioscopic visual findings and cholangi-oscopy-guided forceps biopsy findings for indeterminate biliary lesions: a prospective study","volume":"77","author":"Nishikawa","year":"2013","journal-title":"Gastrointest Endosc"},{"key":"10.5604\/01.3001.0010.5274_bib0200","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3748\/wjg.v22.i5.1891","article-title":"Diagnostic and therapeutic single-operator cholangiopancreatoscopy in biliopancreatic diseases: Prospective multicenter study in Japan","volume":"22","author":"Kurihara","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0205","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1055\/s-0034-1391845","article-title":"Prospective evaluation of the clinical utility of single-operator peroral cholangioscopy in patients with primary sclerosing cholangitis","volume":"47","author":"Arnelo","year":"2015","journal-title":"Endoscopy"},{"key":"10.5604\/01.3001.0010.5274_bib0210","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3109\/00365521.2014.940376","article-title":"Spyglass single-operator peroral cholangioscopy seems promising in the evaluation of primary sclerosing cholangitis-related biliary strictures","volume":"49","author":"Siiki","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4253\/wjge.v6.i4.137","article-title":"Efficacy of SpyGlass(TM)-directed biopsy compared to brush cytology in obtaining adequate tissue for diagnosis in patients with biliary strictures","volume":"6","author":"Rey","year":"2014","journal-title":"World J Gas-trointest Endosc"},{"key":"10.5604\/01.3001.0010.5274_bib0220","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/MOG.0000000000000335","article-title":"Risk of cholangiocarcino-ma in patients with primary sclerosing cholangitis: diagnosis and surveillance","volume":"33","author":"Ehlken","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0225","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.gie.2009.10.041","article-title":"Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment","volume":"71","author":"Gotthardt","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.5604\/01.3001.0010.5274_bib0230","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/MCG.0b013e3181646713","article-title":"A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis","volume":"42","author":"Gluck","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0235","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0016-5107(01)70403-8","article-title":"Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis","volume":"53","author":"Baluyut","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.5604\/01.3001.0010.5274_bib0240","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1111\/j.1572-0241.1999.01364.x","article-title":"Four years experience with short term stenting in primary sclerosing cholangitis","volume":"94","author":"Ponsioen","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0245","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1572-0241.2001.03690.x","article-title":"Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis","volume":"96","author":"Kaya","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0250","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0016-5107(96)70167-0","article-title":"Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis","volume":"44","author":"van Milligen de Wit","year":"1996","journal-title":"Gastrointest Endosc"},{"key":"10.5604\/01.3001.0010.5274_bib0255","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0016-5107(97)70123-8","article-title":"Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis","volume":"46","author":"van Milligen de Wit","year":"1997","journal-title":"Gastrointest En-dosc"},{"key":"10.5604\/01.3001.0010.5274_bib0260","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1055\/s-0032-1325677","article-title":"Risk factors for complications of ERCP in primary sclerosing cholangitis","volume":"44","author":"Ismail","year":"2012","journal-title":"Endoscopy"},{"key":"10.5604\/01.3001.0010.5274_bib0265","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.gie.2014.06.030","article-title":"ERCP-related adverse events in patients with primary sclerosing cholangitis","volume":"81","author":"Navaneethan","year":"2015","journal-title":"Gas-trointest Endosc"},{"key":"10.5604\/01.3001.0010.5274_bib0270","doi-asserted-by":"crossref","first-page":"E710","DOI":"10.1055\/s-0043-102398","article-title":"New approach to decrease post-ERCP adverse events in patients with primary sclerosing cholangitis","volume":"5","author":"Navaneethan","year":"2017","journal-title":"Endosc Int Open"},{"key":"10.5604\/01.3001.0010.5274_bib0275","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2036.2011.04658.x","article-title":"Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis","volume":"33","author":"Culver","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.5604\/01.3001.0010.5274_bib0280","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ajg.2008.161","article-title":"Complications of endoscopic retrograde cholangiopan-creatography in primary sclerosing cholangitis","volume":"104","author":"Bangarulingam","year":"2009","journal-title":"Am J Gas-troenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0285","first-page":"661","article-title":"Endo-scopic therapy of sclerosing cholangitis","volume":"21","author":"Lee","year":"1995","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0010.5274_bib0290","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0168-8278(98)80316-4","article-title":"Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers","volume":"28","author":"Olsson","year":"1998","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0010.5274_bib0295","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.gie.2015.05.018","article-title":"A prospective study of the risk of bacteremia in directed cholangioscopic examination of the common bile duct","volume":"83","author":"Othman","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"10.5604\/01.3001.0010.5274_bib0300","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1053\/j.gastro.2017.06.014","article-title":"Recent Advances in Endoscopy","volume":"153","author":"Wallace","year":"2017","journal-title":"Gastroenterology"},{"issue":"11, Suppl. 2","key":"10.5604\/01.3001.0010.5274_bib0305","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/lt.20938","article-title":"Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"12","author":"Moreno Luna","year":"2006","journal-title":"Liver Transpl"},{"key":"10.5604\/01.3001.0010.5274_bib0310","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJMoa1111103","article-title":"A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis","volume":"366","author":"Elmunzer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.5604\/01.3001.0010.5274_bib0315","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ajg.2012.442","article-title":"Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data","volume":"108","author":"Elmunzer","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.5604\/01.3001.0010.5274_bib0320","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.gie.2016.10.023","article-title":"Rectal indomethacin should be used routinely in all patients for prevention of post-ERCP pancreatitis","volume":"85","author":"Barkin","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"10.5604\/01.3001.0010.5274_bib0325","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cgh.2013.07.026","article-title":"Aggressive hydration with lactated Ringer\u2019s solution reduces pancreatitis after endoscopic retrograde cholangiopancrea-tography","volume":"12","author":"Buxbaum","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0010.5274_bib0330","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cgh.2016.09.001","article-title":"High Volume Lactated Ringer\u2019s for Post-Endo-scopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis: Ready for Prime Time","volume":"15","author":"Singh","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0010.5274_bib0335","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cgh.2017.02.008","article-title":"Indomethacin and Short-Duration Intravenous Hydration as a More Feasible Regimen for Risk Reduction of Post-endoscopic Retrograde Cholangiopancre-atography Pancreatitis","volume":"15","author":"Barkin","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0010.5274_bib0340","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1007\/s10620-013-2608-y","article-title":"ERCP with probe-based confocal laser endomicroscopy for the evaluation of dominant biliary stenoses in primary sclerosing cholangitis patients","volume":"58","author":"Heif","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.5604\/01.3001.0010.5274_bib0345","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10620-015-3827-1","article-title":"Probe-Based Confocal Endomicroscopy in Primary Sclerosing Cholangitis: Not All Inflammatory Strictures Are the Same","volume":"61","author":"Karia","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.5604\/01.3001.0010.5274_bib0350","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/hep.510280316","article-title":"Detection of cholangi-ocarcinoma in primary sclerosing cholangitis by positron emission tomography","volume":"28","author":"Keiding","year":"1998","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0010.5274_bib0355","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1053\/jhep.2001.23912","article-title":"Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer","volume":"33","author":"Kluge","year":"2001","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0010.5274_bib0360","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/hep.21433","article-title":"Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation","volume":"44","author":"Prytz","year":"2006","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0010.5274_bib0365","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0016-5107(02)70117-X","article-title":"Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary strictures","volume":"56","author":"Farrell","year":"2002","journal-title":"Gas-trointest Endosc"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119304508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119304508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:36:47Z","timestamp":1761647807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119304508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1665268119304508"],"URL":"https:\/\/doi.org\/10.5604\/01.3001.0010.5274","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endoscopic Management of Primary Sclerosing Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.5604\/01.3001.0010.5274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}